Steve Farrell

Track

Insider profile

Currently holds positions in Lineage Cell Therapeutics Inc and STAAR Surgical Co

Performance

Overall performance
1.8
Performance over holding periods
1.8
30 days 90 days 120 days
Average return -16% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Lineage Cell Therapeutics Inc March 11, 2013 -
Independent Director STAAR Surgical Co Jan. 1, 2016 -
Independent Director Mallinckrodt Ard Inc Nov. 12, 2007 - Aug. 14, 2014
Steve Farrell's trades of Lineage Cell Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
32.50
Quantity 15,000 -52.4%
Value US$487,569
Transaction date
Planned sale
Price
31.32
Quantity 5,000 -26.8%
Value US$156,590
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2015-11-10 2015-11-06
B Purchase
57,346 +46.0%
153.64
US$3,052,164 		57,346 +46.0% 153.64 US$3,052,164
2014-10-10 2014-10-08
B Purchase
2,251 +3.0%
90.70
US$2,898,976 		2,251 +3.0% 90.70 US$2,898,976
2013-09-13 2013-09-12
B Purchase
42,072 -6.3%
282.63
US$4,848,628 		42,072 -6.3% 282.63 US$4,848,628
2013-08-21 2013-08-20
B Purchase
2,700 +181.6%
3.66
US$9,878 		2,700 +181.6% 3.66 US$9,878
2013-08-21 2013-08-19
B Purchase
1,487 +inf%
3.65
US$5,422 		1,487 +inf% 3.65 US$5,422
2004-10-14 2004-10-12
PlS Planned sale
15,000 -52.4%
32.50
US$487,569 		15,000 -52.4% 32.50 US$487,569
2004-10-05 2004-10-01
PlS Planned sale
5,000 -26.8%
31.32
US$156,590 		5,000 -26.8% 31.32 US$156,590